Shots: Regeneron has submitted a request to the US FDA seeking EUA for its REGN-COV2 investigational Ab regimen to treat COVID-19. If EUA is granted, the US govt. has committed […]readmore
Tags : REGN-COV2
Regeneron’s REGN-COV2 Demonstrate Reduction in Viral Load and Improve Symptoms
Shots: Regeneron reports first data of seamless P-I/II/III study assessing REGN-COV2 that demonstrated a reduction in viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19. It […]readmore
Shots: The two global companies collaborated to develop, manufacture, and distribute REGN-COV2 across the globe. The agreement is expected to increase the supply of REGN-COV2 to at least 3.5 times […]readmore
Shots: Regeneron and the US Government signed $450M contract for the supply of REGN-COV2 which is currently in two P-II/III clinical trials for the treatment and in a P-III trial […]readmore
Shots: The P-III trial involves assessing REGN-COV2 with an expected enrollment of 2000 patients at 100 sites which will be evaluated to prevent infection among uninfected people who have had […]readmore